According to the "Notice on the Results of Handling Misconduct Cases Investigated and Prosecuted in 2022 (The Third Batch)" released by the National Natural Science Foundation of China on October 25, the three doctors involved in Shanghai Jiaotong University's academic misconduct were all criticized in a circular. , a National Natural Science Foundation of China project was withdrawn, and an application for a National Natural Science Foundation of China project was withdrawn.
Recently, after investigation and deliberation by the Supervision Committee of the National Natural Science Foundation of China and approval by the executive meeting of the National Natural Science Foundation of China, the National Natural Science Foundation of China has dealt with the subjects involved in relevant scientific research misconduct cases. The relevant cases and handling results of the criticisms will now be notified:
(1) Announcement on the problems of data fraud in the papers published by Li Qifeng and Ma Jie and the results of false information processing in the project final report
The Supervision Committee of the National Natural Science Foundation of China launched an investigation into two papers published by Li Qifeng and Ma Jie of Shanghai Jiaotong University for suspected academic misconduct. The papers involved are as follows:
Paper 1: Qifeng Li, Ke Shen, Yang Zhao, Xiaoguang He, Chenkai Ma, Lin Wang, Baocheng Wang, Jianwen Liu, Jie Ma*. MicroRNA-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt/β-catenin signaling pathway. FEBS letters, 2013, 587, 12. (marked with fund number 81271382)
Paper 2: Qifeng Li, Ke Shen, Yang Zhao, Chenkai Ma, Jianwen Liu., Jie Ma*. MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway. Journal of Translational Medicine, 2013, 11, 302. (marked with fund number 81271382)
After investigation, papers 1 and 2 have data fraud problems, and the first author Li Qifeng and the corresponding author Ma Jie are responsible for the above problems. In addition, Ma Jie included 2 papers in the final report of the National Natural Science Foundation of China (Grant No. 81271382), and is also responsible for the objective results of false information in the final report.
After deliberation at the 14th meeting of the Fifth Supervision Committee of the National Natural Science Foundation of China and the 10th executive meeting of the National Natural Science Foundation of China in 2022, it was decided to follow the "Measures for Investigation and Handling of Scientific Research Misconduct of National Natural Science Foundation of China" forty Articles 7 and 40: Li Qifeng's qualifications for applying for and participating in the National Natural Science Foundation of China will be cancelled for 3 years (July 19, 2022 to July 18, 2025), and Li Qifeng will be given a notice of criticism.
Decided to revoke the Ma Jie National Natural Science Foundation of Experimental Research on the Therapeutic Potential of iPS Cell Transplantation” (Approval No. 81271382), recover the allocated funds, cancel the Ma Jie National Natural Science Foundation of China project application and participation application qualification for 3 years (July 19, 2022 to July 18, 2025) ), and gave Ma Jie a bulletin of criticism.
(2) Announcement on the results of handling the plagiarism problem in the application form of Lifeng National Natural Science Foundation of China
The Supervision Committee of the National Natural Science Foundation of China launched an investigation into Shanghai Jiaotong University Lifeng's alleged academic misconduct.
After investigation, Lifeng used the content of other people's application to apply for the National Natural Science Foundation of China "Research on the mechanism of acute hyperglycemia-induced spleen SND1-AGTR1 pathway involved in acute myocardial ischemia-reperfusion injury" (application number 8227022167), and there is plagiarism from others' projects. Lifeng shall be responsible for the above-mentioned problems with regard to the content of the application.
After deliberation at the 14th meeting of the Fifth Supervision Committee of the National Natural Science Foundation of China and the 10th executive meeting of the National Natural Science Foundation of China in 2022, it was decided to follow the "Measures for Investigation and Handling of Scientific Research Misconduct of National Natural Science Foundation of China" forty Article, withdraw the Lifeng National Natural Science Foundation of China project "Acute hyperglycemia-induced spleen SND1-AGTR1 pathway in the mechanism of acute myocardial ischemia-reperfusion injury" (application number 8227022167) application, cancel Lifeng National Natural Science Foundation project application and participation Eligibility to apply for 3 years (July 19, 2022 to July 18, 2025), Lifeng will be given a notice of criticism.
On October 25, the website of the National Natural Science Foundation of China announced the "Decision on the Handling of Misconduct Cases Investigated and Prosecuted in 2022 (The Third Batch)". The number of handling decisions this time is as high as 46, far higher than the 12 cases investigated and dealt with in September this year. , 70% of which are from the biological or medical fields.
